序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
141 Systems and methods for processing cells US14547966 2014-11-19 US08967513B1 2015-03-03 Rouzbeh R. Taghizadeh; John Meade
The present invention efficiently and cost-effectively extracts and collects cells from a tissue. The inventors have discovered that the tissue can be effectively fragmented and the resulting cells can be purified using a system or kit with multiple components. An advantage of the present invention is that tissue processing takes place in a closed system such that sterility can be maintained throughout the process, even if certain components are removed during processing, for example through the use of valves, clamps, and heal seals. Furthermore, any or all of the steps can be automated or manually accomplished, according to the specific needs of the application or the user.
142 Systems and methods for processing cells US13933034 2013-07-01 US08893995B2 2014-11-25 Rouzbeh R. Taghizadeh; John Meade
The present invention efficiently and cost-effectively extracts and collects cells from a tissue. The inventors have discovered that the tissue can be effectively fragmented and the resulting cells can be purified using a system or kit with multiple components. An advantage of the present invention is that tissue processing takes place in a closed system such that sterility can be maintained throughout the process, even if certain components are removed during processing, for example through the use of valves, clamps, and heat seals. Furthermore, any or all of the steps can be automated or manually accomplished, according to the specific needs of the application or the user.
143 Postpartum-derived cells for use in treatment of disease of the heart and circulatory system US10877445 2004-06-25 US08703121B2 2014-04-22 Ian Ross Harris; Alexander M. Harmon; Anthony J. Kihm; Anna Gosiewska
Cells derived from postpartum tissue and methods for their use in treatment of diseases of the heart or circulatory system are disclosed. Cells may be used in either differentiated or undifferentiated forms, in homogenous cultures, or as populations with other cells, and in conjunction with other bioactive factors.
144 SYSTEMS AND METHODS FOR PROCESSING CELLS US13933034 2013-07-01 US20130295673A1 2013-11-07 Rouzbeh R. Taghizadeh; John Meade
The present invention efficiently and cost-effectively extracts and collects cells from a tissue. The inventors have discovered that the tissue can be effectively fragmented and the resulting cells can be purified using a system or kit with multiple components. An advantage of the present invention is that tissue processing takes place in a closed system such that sterility can be maintained throughout the process, even if certain components are removed during processing, for example through the use of valves, clamps, and heat seals. Furthermore, any or all of the steps can be automated or manually accomplished, according to the specific needs of the application or the user.
145 HAIR FOLLICLE MESENCHYMAL STEM CELLS AND USE THEREOF US13661782 2012-10-26 US20130115198A1 2013-05-09 ROLF HOFFMANN; KEVIN J. MCELWEE
The present invention relates to a method for isolating hair follicle mesenchymal stem cells and to the use thereof for therapy and prophylaxis as well as for cosmetic treatments.
146 REGENERATION AND REPAIR OF NEURAL TISSUE USING POSTPARTUM-DERIVED CELLS US13605716 2012-09-06 US20130022585A1 2013-01-24 DARIN J. MESSINA; Sanjay Mistry; Alexander M. Harmon; Ian Ross Harris; Anthony J. Kihm; Agnieszka Seyda; Chin-Feng Yi; Anna Gosiewska
Cells derived from postpartum umbilicus and placenta are disclosed. Pharmaceutical compositions, devices and methods for the regeneration or repair of neural tissue using the postpartum-derived cells are also disclosed.
147 METHODS AND APPARATUS FOR ENHANCED RECOVERY OF CELLS AND OF CELL-ENRICHED MATRIX FROM TISSUE SAMPLES US13329143 2011-12-16 US20120195863A1 2012-08-02 Eckhard U. Alt; Michael E. Coleman; Ron Stubbers
This document describes methods and an apparatus for recovery of a cell-enriched matrix and cells (e.g., regenerative cells) from a tissue sample. In some embodiments, at least two rounds of acceleration and deceleration are performed.
148 Method for isolation of inner cell mass and method of preparation of embryonic stem cell lines using inner cell mass isolated by the same US12459869 2009-07-10 US08093051B2 2012-01-10 Chang Hyun Kim
A method for isolation of an inner cell mass and a method for preparation of embryonic stem cell lines using the inner cell mass isolated by the same. A blastocyst being free from a zona pellucida removed therefrom is placed on a feeder cell, and a micro cover glass is put on the blastocyst to apply pressure caused by a weight of the micro cover glass, to the blastocyst for a desired time, so that the inner cell mass may be obtained with considerably improved yield compared to conventional methods, and therefore, an embryonic stem cell line may be efficiently established and proliferated.
149 POSTPARTUM CELLS DERIVED FROM UMBILICAL CORD TISSUE, AND METHODS OF MAKING AND USING THE SAME US12389305 2009-02-19 US20100210013A1 2010-08-19 Sanjay Mistry; Anthony J. Kihm; Ian Ross Harris; Alexander M. Harmon; Darin J. Messina; Agnieszka Seyda; Chin-Feng Yi; Anna Gosiewska
Cells derived from human umbilical cords are disclosed along with methods for their therapeutic use. Isolation techniques, culture methods and detailed characterization of the cells with respect to their cell surface markers, gene expression, and their secretion of trophic factors are described.
150 Soft tissue repair and regeneration using postpartum-derived cells US10877009 2004-06-25 US07560276B2 2009-07-14 Alexander M. Harmon; Ian Ross Harris; Anthony J. Kihm; Sanjay Mistry; Darin J. Messina; Agnieszka Seyda; Chin-Feng Yi; Anna Gosiewska
Cells derived from postpartum tissue having the potential to support cells of and/or differentiate to cells of a soft tissue lineage, and methods of preparation and use of those postpartum tissue-derived cells, are provided by the invention. The invention also provides methods for the use of such postpartum-derived cells and products related thereto in therapies for conditions of soft tissue.
151 Regeneration and repair of neural tissue using postpartum-derived cells US10877269 2004-06-25 US07524489B2 2009-04-28 Darin J. Messina; Sanjay Mistry; Alexander M. Harmon; Ian Ross Harris; Anthony J. Kihm; Agnieszka Seyda; Chin-Feng Yi
Cells derived from postpartum umbilicus and placenta are disclosed. Pharmaceutical compositions, devices and methods for the regeneration or repair of neural tissue using the postpartum-derived cells are also disclosed.
152 Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same US10877012 2004-06-25 US07510873B2 2009-03-31 Sanjay Mistry; Anthony J. Kihm; Ian Ross Harris; Alexander M. Harmon; Darin J. Messina; Chin-Feng Yi; Anna Gosiewska
Cells derived from human umbilical cords are disclosed along with methods for their therapeutic use. Isolation techniques, culture methods and detailed characterization of the cells with respect to their cell surface markers, gene expression, and their secretion of trophic factors are described.
153 Treatment of retinitis pigmentosa with human umbilical cord cells US10877541 2004-06-25 US07413734B2 2008-08-19 Sanjay Mistry; Darin J. Messina; Ian Ross Harris; Alexander M. Harmon; Agnieszka Seyda; Chin-Feng Yi; Anna Gosiewska
Cells derived from postpartum umbilicus and placenta are disclosed. Pharmaceutical compositions, devices and methods for the regeneration or repair of ocular tissue using the postpartum-derived cells are also disclosed.
154 Soft tissue repair and regeneration using postpartum-derived cells and cell products US11316104 2005-12-22 US20060153816A1 2006-07-13 Laura Brown; Alexander Harmon; Anna Gosiewska
Cells derived from postpartum tissue and products thereof having the potential to support cells of and/or differentiate to cells of a soft tissue lineage, and methods of preparation and use of those postpartum tissue-derived cells, are provided by the invention. The invention also provides methods for the use of such postpartum-derived cells and products related thereto in therapies for conditions of soft tissue.
155 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same US10877012 2004-06-25 US20050054098A1 2005-03-10 Sanjay Mistry; Anthony Kihm; Ian Harris; Alexander Harmon; Darin Messina; Agnieszka Seyda; Chin-Feng Yi; Anna Gosiewska
Cells derived from human umbilical cords are disclosed along with methods for their therapeutic use. Isolation techniques, culture methods and detailed characterization of the cells with respect to their cell surface markers, gene expression, and their secretion of trophic factors are described.
156 Repair and regeneration of ocular tissue using postpartum-derived cells US10877541 2004-06-25 US20050037491A1 2005-02-17 Sanjay Mistry; Darin Messina; Ian Harris; Alexander Harmon; Anthony Kihm; Agnieszka Seyda; Chin-Feng Yi; Anna Gosiewska
Cells derived from postpartum umbilicus and placenta are disclosed. Pharmaceutical compositions, devices and methods for the regeneration or repair of ocular tissue using the postpartum-derived cells are also disclosed.
157 Adhesive signature-based methods for the isolation of stem cells and cells derived therefrom US14128547 2012-06-21 US10106780B2 2018-10-23 Ankur Singh; Shalu Suri; Todd Christopher McDevitt; Hang Lu; Andres Jose Garcia
The present invention provides for methods of isolating a stem cell or cell derived therefrom from a mixture of cells, for example, a mixture of adherent cells in culture. Cell isolation is achieved by the application of selective detachment forces.
158 METHOD FOR CULTURING PRIMARY CELLS US15444588 2017-02-28 US20180023055A1 2018-01-25 Norikatsu MIYOSHI; Shiki FUJINO; Masayuki OHUE; Masayoshi YASUI
Method for producing a primary culture of cancer cells, comprising: (a) fragmenting cancer tissues derived from a living body and removing impurities from the fragmented cancer tissues, (b) subjecting the tissue masses obtained in (a) to suspension culture, and (c) subjecting the culture obtained in (b) to adherent culture.
159 SYSTEMS FOR DISSOCIATION OF BIOLOGICAL TISSUES US15532854 2015-12-04 US20170355950A1 2017-12-14 Yitshak ZOHAR; Linda L. RESTIFO; Linan JIANG
Provided herein is technology relating to processing biological samples and particularly, but not exclusively, to systems and apparatuses for dissociating biological tissues into viable cells.
160 STEM CELLS & DECELLULARIZED TISSUE MATRIX FROM CORD TISSUE US15613264 2017-06-05 US20170327792A1 2017-11-16 Raymond MOUZANNAR
Methods and products obtained from the method for isolating and culturing mixed populations of stem cells, making decellularized tissue matrix, making decellularized tissue matrix infused with said mixed populations of stem cells, and methods of stem cell therapy are provided.
QQ群二维码
意见反馈